NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Overview Fund Activity
Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

31 hedge funds and large institutions have $224K invested in NKGen Biotech, Inc. Warrants in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.

Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
1
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$2K

Top Buyers

1
SFA
1
Sequoia Financial Advisors
Ohio
$1.37K
2
CAC
2
Cowen and Company
New York
$3.46K
3
FTUS
3
Flow Traders U.S.
New York
$1K
4
Citadel Advisors
4
Citadel Advisors
Florida
$2.63K
5
WAM
5
Wolverine Asset Management
Illinois
$2.45K

Top Sellers

1
PC
1
Periscope Capital
Ontario, Canada
$1.89K
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$0
3
VF
3
Virtu Financial
New York
$0
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$14K
5
TCA
5
Taconic Capital Advisors
New York
$6.92K
Name Holding Trade Value Shares
Change 		Shares
Change %
GF
26
Gabelli Funds
New York
$1.5K – – –
SFA
27
Sequoia Financial Advisors
Ohio
$1.37K +$1.37K +14,072 New
UBS Group
28
UBS Group
Switzerland
$1.32K -$3 -34 -0.2%
CL
29
CSS LLC
Illinois
$1.25K – – –
FTUS
30
Flow Traders U.S.
New York
$1K +$1K +15,246 New
CCM
31
CAAS Capital Management
New York
$870 – – –
VF
32
Virtu Financial
New York
– -$2K -13,631 Closed
JPMorgan Chase & Co
33
JPMorgan Chase & Co
New York
– -$2.95K – –
1
2